Hyaluronidase Market By Type (Animal-derived Hyaluronidase, Synthetic Hyaluronidase), By Application (Chemotherapy, Dermatology, Ophthalmology, Plastic Surgery and Others): Global Industry Perspective, Comprehensive Analysis and Forecast, 2020 – 2026

Published Date: 20-Jan-2021 Category: Chemical & Materials Report Format : PDF Pages: 110 Report Code: ZMR-5691 Status : Published

The Hyaluronidase market is set for a rapid growth over the forecast period. In terms of revenue, the global Hyaluronidase market accounted for USD 707.73 Million in 2019 and is expected to reach USD 1,290.86 Million by 2026, growing at a CAGR of 8.97%.

Description

The Hyaluronidase market is set for a rapid growth over the forecast period. In terms of revenue, the global Hyaluronidase market accounted for USD 707.73 Million in 2019 and is expected to reach USD 1,290.86 Million by 2026, growing at a CAGR of 8.97%.

Global Hyaluronidase Market: Overview

Hyaluronic acid, also referred to as hyaluronan, is a clear, gooey material that your body naturally produces. Hyaluronic acid is found all over the body in conjunctive tissue, skin, within the eye and fluids in the joints. It allows fluids to have a texture similar to glue, which may help to moisten tissues and joints and secure them. In medicine, hyaluronidase is produced in the laboratory and given by injection under the skin with other medicines to treat certain conditions. The use of hyaluronidase to break down hyaluronic acid helps to thin out the fluids and connective tissue so that the medicines can pass into the tissues more easily.

In clinical practice, hyaluronidase use has become more broad and common. It is used, in particular, to resolve the discomfort of patients following treatment with hyaluronic acid filler and to treat side effects. It is increasingly necessary for clinicians to have adequate knowledge of hyaluronidase as its use becomes more widespread. If it is used with a comprehensive understanding of its modes of action, side-effects and metabolism, hyaluronidase can serve as an effective therapy in a variety of situations.

Global Hyaluronidase Market: Growth Factors

Hyaluronidase is used in cosmetic therapies, cancer treatments and ophthalmic medicinal solutions. Due to the use of enzyme-based substrates for non – invasive disease diagnosis, its evolving position in cancer metastasis and treatment is expected to drive demand and subsequent market growth across profitable avenues.

In addition, growing understanding of physical appearance alterations has resulted in an increasing number for cosmetics and aesthetic treatments. Demand for hyaluronidase in cosmetic dermatology is growing, driven primarily by an increased incidence of skin disorders and easy access in different regions to modern cosmetic treatments. Increasing geriatric demographics, favorable reimbursement policies, and a number of people opting for cosmetic nonsurgical procedures are other factors responsible for the projected development. Hyaluronidase therapy can resolve fillers injected in high amounts and may also help dissolve subcutaneous nodules. This has intensified the interest of cosmetic industry practitioners in acquiring awareness of the use, working principle, and harmful impacts of this enzyme.

Therefore, the therapist should be well versed with the correct dosage of hyaluronidase along with any complications and remedies that may be required. Rising developments targeted at decreasing the side-effects of hyaluronidase administration are anticipated to fuel the growth for companies operating in this hyaluronidase market.

Global Hyaluronidase Market: Segmentation

In order to ensure that the goods are correctly chosen, clinicians must be informed of the distinct characteristics of the sources. Practitioners need to evaluate the items from the right source in order to make effective choices when suggesting care to patients. The most widely used animal sources contain porcine and bovine products, while synthetic ones are extracted from recombinant human sources. Animal-derived goods had the highest market share in 2019. It is expected to retain its dominance over the forecast era, as most licensed and commercialized brands are currently produced from animal sources. However, the limitations related to products produced from animals have contributed to the production and use of synthetic products. A few other studies have shown the beneficial effects of recombinant human hyaluronidase in improving the consistency and protection of local anesthetic blocks.

Hyaluronidase depolymerizes hyaluronic acid and increases the absorption of connective tissues. These properties have led to several applications in recent years. Hyaluronidase has been increased, particularly in medicinal products, to stimulate the absorption and dispersion of other injected medicines. Hyaluronidase is also finding positive reviews and expanded use in chemotherapy and osteoarthritis contributes to consumer sales.

The growing importance of the use of hyaluronidase in dermatology has led to the highest generation of sales. The establishment of a standard protocol is projected to increase the traction of market growth in the coming years. Injections have been used for indications of chemotherapy. They are typically intended for the treatment of extravasation that may ultimately lead to necrosis of tissues. Several research and case studies have proposed its use to counter extravasation. Utility as an alternative in chemotherapy is associated with improved tumor response to chemo drugs as demonstrated in clinical trials and laboratory animal models linked to this enzyme.

Global Hyaluronidase Market: Regional Analysis

It is expected that an increase in the number of experimental procedures that include an in-vitro assessment of the biological availability of hyaluronidase would increase product penetration in different regions around the globe. In 2019, North America held the largest market share, owing to the involvement of key players making these goods, the high acceptance of innovative treatment options, and a significant number of dermatology clinics recommending such procedures.

Asia Pacific is predicted to see the highest growth in the near future as a result of medical tourism for dermatology and chemotherapy applications in various countries. This has facilitated investments in Asia Pacific by many foreign companies. The presence of a large number of manufacturers, combined with the advent of technology in South Korea, is an opportunity to push the Asian market at a lucrative rate. After China, South Korea is second in terms of revenue production on the Asian market. In July 2018, Alteogen created the world's second-largest recombinant human hyaluronidase protein and proprietary protein engineering technology.

Global Hyaluronidase Market: Competitive Players

Some of key players in Hyaluronidase market are Amphastar Pharmaceuticals, Inc., Bausch & Lomb Incorporated, Halozyme, Inc., PrimaPharma, Inc., Shreya Life Sciences Pvt. Ltd., STEMCELL Technologies Inc., Alteogen lnc., Sun Pharmaceutical Industries Ltd., and The Cooper Companies among others. 

Global Hyaluronidase Market: Regional Segment Analysis

  • North America
    • The U.S.
    • Canada
  • Europe
    • France
    • The UK
    • Spain
    • Germany
    • Italy
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Southeast Asia
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa
    • GCC
    • South Africa
    • Rest of Middle East & Africa

Table Of Content

  • Chapter 1.Preface
    • 1.1.Report Description
    • 1.2.Report Scope
  • Chapter 2.Research Methodulogy
    • 2.1.Research Methodulogy
    • 2.2.Secondary Research
    • 2.3.Primary Research
    • 2.4.Models
      • 2.4.1.Company Share Analysis Model
      • 2.4.2.Revenue Based Modeling
    • 2.5.Research Limitations
  • Chapter 3.Executive Summary
    • 3.1.Global Hyaluronidase Market, 2016 – 2026 (USD Million)
    • 3.2.Global Hyaluronidase Market: Snapshot
  • Chapter 4.Hyaluronidase Market – Industry Analysis
    • 4.1.Introduction
    • 4.2.Market Drivers
    • 4.3.Market Restraints
    • 4.4.Market Opportunities
    • 4.5.Porter’s Five Forces Analysis
    • 4.6.COVID 19 Impact Analysis
  • Chapter 5.Investment Proposition Analysis
    • 5.1.Global Hyaluronidase Market Attractiveness, By Type
    • 5.2.Global Hyaluronidase Market Attractiveness, By Application
    • 5.3.Global Hyaluronidase Market Attractiveness, By Region
  • Chapter 6.Competitive Landscape
    • 6.1.Company Market Share Analysis - 2019
      • 6.1.1.Global Hyaluronidase Market: Company Market Share, 2019
    • 6.2.Strategic Developments
  • Chapter 7.Hyaluronidase Market – Type Segment Analysis
    • 7.1.Global Hyaluronidase Market Overview: by Type
      • 7.1.1.Global Hyaluronidase Market Revenue Share, by Type, 2019 & 2026
    • 7.2.Global Hyaluronidase Market Analysis/Overview – By Type
      • 7.2.1.Animal-derived Hyaluronidase – Overview/Analysis
      • 7.2.2.Synthetic Hyaluronidase – Overview/Analysis
    • 7.3.Animal-derived Hyaluronidase
      • 7.3.1.Global Hyaluronidase Market for Animal-derived Hyaluronidase, Revenue (USD Million) 2016 - 2026
    • 7.4.Synthetic Hyaluronidase
      • 7.4.1.Global Hyaluronidase Market for Synthetic Hyaluronidase, Revenue (USD Million) 2016 – 2026
  • Chapter 8.Hyaluronidase Market – Application Segment Analysis
    • 8.1.Global Hyaluronidase Market Overview: by Application
      • 8.1.1.Global Hyaluronidase Market Revenue Share, by Application, 2019 & 2026
    • 8.2.Global Hyaluronidase Market Analysis/Overview – By Application
      • 8.2.1.Chemotherapy – Overview/Analysis
      • 8.2.2.Dermatulogy – Overview/Analysis
      • 8.2.3.Ophthalmulogy– Overview/Analysis
      • 8.2.4.Plastic Surgery– Overview/Analysis
      • 8.2.5.Others – Overview/Analysis
    • 8.3.Chemotherapy
      • 8.3.1.Global Hyaluronidase Market for Chemotherapy, Revenue (USD Million) 2016 - 2026
    • 8.4.Dermatulogy
      • 8.4.1.Global Hyaluronidase Market for Dermatulogy, Revenue (USD Million) 2016 - 2026
    • 8.5.Ophthalmulogy
      • 8.5.1.Global Hyaluronidase Market for Ophthalmulogy, Revenue (USD Million) 2016 – 2026
    • 8.6.Plastic Surgery
      • 8.6.1.Global Hyaluronidase Market for Plastic Surgery, Revenue (USD Million) 2016 – 2026
    • 8.7.Others
      • 8.7.1.Global Hyaluronidase Market for Others, Revenue (USD Million) 2016 - 2026
  • Chapter 9.Hyaluronidase Market – Regional Analysis
    • 9.1.Global Hyaluronidase Market: Regional Overview
      • 9.1.1.Global Hyaluronidase Market Revenue Share, by Region, 2019 & 2026
      • 9.1.2.Global Hyaluronidase Market Revenue, by Region, 2016 – 2026 (USD Million)
    • 9.2.North America
      • 9.2.1.North America Hyaluronidase Market Revenue, 2016 - 2026 (USD Million)
      • 9.2.2.North America Hyaluronidase Market Revenue, by Country, 2016 – 2026 (USD Million)
      • 9.2.3.North America Hyaluronidase Market Revenue, by Type, 2016 – 2026
      • 9.2.4.North America Hyaluronidase Market Revenue, by Application, 2016 – 2026
      • 9.2.5.U.S.
      • 9.2.6.Canada
    • 9.3.Europe
      • 9.3.1.Europe Hyaluronidase Market Revenue, 2016 - 2026 (USD Million)
      • 9.3.2.Europe Hyaluronidase Market Revenue, by Country, 2016 – 2026 (USD Million)
      • 9.3.3.Europe Hyaluronidase Market Revenue, by Type, 2016 – 2026
      • 9.3.4.Europe Hyaluronidase Market Revenue, by Application, 2016 – 2026
      • 9.3.5.Germany
      • 9.3.6.France
      • 9.3.7. U.K.
      • 9.3.8.Rest of Europe
    • 9.4.Asia Pacific
      • 9.4.1.Asia Pacific Hyaluronidase Market Revenue, 2016 - 2026 (USD Million)
      • 9.4.2.Asia Pacific Hyaluronidase Market Revenue, by Country, 2016 – 2026 (USD Million)
      • 9.4.3.Asia Pacific Hyaluronidase Market Revenue, by Type, 2016 – 2026
      • 9.4.4.Asia Pacific Hyaluronidase Market Revenue, by Application, 2016 – 2026
      • 9.4.5.China
      • 9.4.6.Japan
      • 9.4.7.India
      • 9.4.8.Rest of Asia Pacific
    • 9.5.Latin America
      • 9.5.1.Latin America Hyaluronidase Market Revenue, 2016 - 2026 (USD Million)
      • 9.5.2.Latin America Hyaluronidase Market Revenue, by Country, 2016 – 2026 (USD Million)
      • 9.5.3.Latin America Hyaluronidase Market Revenue, by Type, 2016 – 2026
      • 9.5.4.Latin America Hyaluronidase Market Revenue, by Application, 2016 – 2026
      • 9.5.5.Brazil
      • 9.5.6.Mexico
      • 9.5.7.Rest of Latin America
    • 9.6.The Middle-East and Africa
      • 9.6.1.The Middle-East and Africa Hyaluronidase Market Revenue, 2016 - 2026 (USD Million)
      • 9.6.2.The Middle-East and Africa Hyaluronidase Market Revenue, by Country, 2016 – 2026 (USD Million)
      • 9.6.3.The Middle-East and Africa Hyaluronidase Market Revenue, by Type, 2016 – 2026
      • 9.6.4.The Middle-East and Africa Hyaluronidase Market Revenue, by Application, 2016 – 2026
  • Chapter 10.Company Profiles
    • 10.1.Amphastar Pharmaceuticals, Inc.
    • 10.2.Bausch & Lomb Incorporated
    • 10.3.Halozyme, Inc.
    • 10.4.PrimaPharma, Inc.
    • 10.5.Shreya Life Sciences Pvt. Ltd.
    • 10.6.STEMCELL Technulogies Inc.
    • 10.7.Sun Pharmaceutical Industries Ltd.
    • 10.8.The Cooper Companies Inc.
    • 10.9.Alteogen lnc.,
    • 10.1.Others

Methodology

Office Address

Corporate Office
Zion Market Research 244 Fifth Avenue, Suite N202 New York, 10001, United States
Tel: +49-322 210 92714
USA/Canada Toll Free No.1-855-465-4651

Asia Pacific Office
3rd Floor, Mrunal Paradise, Opp Maharaja Hotel, Pimple Gurav, Pune 411061, Maharashtra, India
Phone No 020-46277770

Contact #
US OFFICE NO +1-386-310-3803
US/CAN TOLL FREE +1-855-465-4651
Email: sales@zionmarketresearch.com

We Accept

We have secured system to process your transaction.


We Are On Social